Baidu
map

Acta Clin Croat:彩色多普勒超声检测早期甲状腺功能亢进视神经病变的眼眶血管的血流变化

2018-11-25 MedSci MedSci原创

克罗地亚斯普利特大学医院中心眼科的LesinM等人近日在Acta Clin Croat上发表了一项重要工作。甲状腺相关眼眶病(TAO)是一种格雷夫斯病的常见表现。在TAO中约有6%的患者会发展为甲状腺功能亢进性视神经病变(DON),而这是TAO最严重的并发症。该研究的目的就是研究其发生过程。

克罗地亚斯普利特大学医院中心眼科的LesinM等人近日在Acta Clin Croat上发表了一项重要工作。甲状腺相关眼眶病(TAO)是一种格雷夫斯病的常见表现。在TAO中约有6%的患者会发展为甲状腺功能亢进性视神经病变(DON),而这是TAO最严重的并发症。该研究的目的就是研究其发生过程。

由于DON可导致永久性损伤,因此在视力损伤的初始阶段,及视力有可能恢复的情况下,及早发现DON是至关重要的。彩色多普勒超声是一种非侵入性诊断方法,可用于早期发现DON。

在确诊的36名格雷夫斯病和活动性TAO的患者,其中21名(58%)患有早期DON(eDON),另外15名(42%)没有任何的eDON症状。所有纳入研究的患者均进行了多普勒超声检查以确定颈内动脉、眼动脉和视网膜中央动脉的血流速率等情况。

研究结果显示,彩色多普勒超声检查可以检测到eDON患者的眼眶血流变化。早期发现DON可以进行早期治疗,并可以预防永久性视神经损伤。

原文出处:

Lesin, M., et al., Flow Changes in Orbital Vessels Detected with Color Doppler Ultrasound in Patients with Early Dysthyroid Optic Neuropathy. Acta Clin Croat, 2018. 57(2): p. 301-306.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1798701, encodeId=80711e9870135, content=<a href='/topic/show?id=92346985ed2' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69857, encryptionId=92346985ed2, topicName=甲状腺功能亢进视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Mon Feb 25 13:12:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926539, encodeId=0811192653949, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Wed Mar 27 09:12:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812146, encodeId=8b1c181214630, content=<a href='/topic/show?id=536e89169b0' target=_blank style='color:#2F92EE;'>#血流变化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89169, encryptionId=536e89169b0, topicName=血流变化)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Sep 18 12:12:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1768950, encodeId=f0211e6895058, content=<a href='/topic/show?id=9f12432880c' target=_blank style='color:#2F92EE;'>#多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43288, encryptionId=9f12432880c, topicName=多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c58d37960304, createdName=12499e01m59暂无昵称, createdTime=Thu Jun 27 18:12:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857723, encodeId=02ff185e723b9, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jan 20 18:12:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1653874, encodeId=2f3916538e4f8, content=<a href='/topic/show?id=230250248f9' target=_blank style='color:#2F92EE;'>#彩色多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50248, encryptionId=230250248f9, topicName=彩色多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=804e24388072, createdName=wleon8903, createdTime=Tue Dec 04 23:12:00 CST 2018, time=2018-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661544, encodeId=ff48166154426, content=<a href='/topic/show?id=aea3131932d' target=_blank style='color:#2F92EE;'>#OAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13193, encryptionId=aea3131932d, topicName=OAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37ad25322582, createdName=12498561m40(暂无昵称), createdTime=Sat Nov 09 05:12:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666980, encodeId=7613166698080, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Thu Mar 28 09:12:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849623, encodeId=5f1f1849623f1, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Tue Feb 05 14:12:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273716, encodeId=9d8512e371628, content=<a href='/topic/show?id=10a5698555f' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69855, encryptionId=10a5698555f, topicName=甲状腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Tue Nov 27 14:12:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1798701, encodeId=80711e9870135, content=<a href='/topic/show?id=92346985ed2' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69857, encryptionId=92346985ed2, topicName=甲状腺功能亢进视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Mon Feb 25 13:12:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926539, encodeId=0811192653949, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Wed Mar 27 09:12:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812146, encodeId=8b1c181214630, content=<a href='/topic/show?id=536e89169b0' target=_blank style='color:#2F92EE;'>#血流变化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89169, encryptionId=536e89169b0, topicName=血流变化)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Sep 18 12:12:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1768950, encodeId=f0211e6895058, content=<a href='/topic/show?id=9f12432880c' target=_blank style='color:#2F92EE;'>#多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43288, encryptionId=9f12432880c, topicName=多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c58d37960304, createdName=12499e01m59暂无昵称, createdTime=Thu Jun 27 18:12:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857723, encodeId=02ff185e723b9, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jan 20 18:12:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1653874, encodeId=2f3916538e4f8, content=<a href='/topic/show?id=230250248f9' target=_blank style='color:#2F92EE;'>#彩色多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50248, encryptionId=230250248f9, topicName=彩色多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=804e24388072, createdName=wleon8903, createdTime=Tue Dec 04 23:12:00 CST 2018, time=2018-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661544, encodeId=ff48166154426, content=<a href='/topic/show?id=aea3131932d' target=_blank style='color:#2F92EE;'>#OAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13193, encryptionId=aea3131932d, topicName=OAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37ad25322582, createdName=12498561m40(暂无昵称), createdTime=Sat Nov 09 05:12:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666980, encodeId=7613166698080, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Thu Mar 28 09:12:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849623, encodeId=5f1f1849623f1, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Tue Feb 05 14:12:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273716, encodeId=9d8512e371628, content=<a href='/topic/show?id=10a5698555f' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69855, encryptionId=10a5698555f, topicName=甲状腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Tue Nov 27 14:12:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1798701, encodeId=80711e9870135, content=<a href='/topic/show?id=92346985ed2' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69857, encryptionId=92346985ed2, topicName=甲状腺功能亢进视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Mon Feb 25 13:12:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926539, encodeId=0811192653949, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Wed Mar 27 09:12:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812146, encodeId=8b1c181214630, content=<a href='/topic/show?id=536e89169b0' target=_blank style='color:#2F92EE;'>#血流变化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89169, encryptionId=536e89169b0, topicName=血流变化)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Sep 18 12:12:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1768950, encodeId=f0211e6895058, content=<a href='/topic/show?id=9f12432880c' target=_blank style='color:#2F92EE;'>#多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43288, encryptionId=9f12432880c, topicName=多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c58d37960304, createdName=12499e01m59暂无昵称, createdTime=Thu Jun 27 18:12:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857723, encodeId=02ff185e723b9, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jan 20 18:12:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1653874, encodeId=2f3916538e4f8, content=<a href='/topic/show?id=230250248f9' target=_blank style='color:#2F92EE;'>#彩色多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50248, encryptionId=230250248f9, topicName=彩色多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=804e24388072, createdName=wleon8903, createdTime=Tue Dec 04 23:12:00 CST 2018, time=2018-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661544, encodeId=ff48166154426, content=<a href='/topic/show?id=aea3131932d' target=_blank style='color:#2F92EE;'>#OAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13193, encryptionId=aea3131932d, topicName=OAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37ad25322582, createdName=12498561m40(暂无昵称), createdTime=Sat Nov 09 05:12:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666980, encodeId=7613166698080, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Thu Mar 28 09:12:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849623, encodeId=5f1f1849623f1, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Tue Feb 05 14:12:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273716, encodeId=9d8512e371628, content=<a href='/topic/show?id=10a5698555f' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69855, encryptionId=10a5698555f, topicName=甲状腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Tue Nov 27 14:12:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1798701, encodeId=80711e9870135, content=<a href='/topic/show?id=92346985ed2' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69857, encryptionId=92346985ed2, topicName=甲状腺功能亢进视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Mon Feb 25 13:12:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926539, encodeId=0811192653949, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Wed Mar 27 09:12:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812146, encodeId=8b1c181214630, content=<a href='/topic/show?id=536e89169b0' target=_blank style='color:#2F92EE;'>#血流变化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89169, encryptionId=536e89169b0, topicName=血流变化)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Sep 18 12:12:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1768950, encodeId=f0211e6895058, content=<a href='/topic/show?id=9f12432880c' target=_blank style='color:#2F92EE;'>#多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43288, encryptionId=9f12432880c, topicName=多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c58d37960304, createdName=12499e01m59暂无昵称, createdTime=Thu Jun 27 18:12:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857723, encodeId=02ff185e723b9, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jan 20 18:12:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1653874, encodeId=2f3916538e4f8, content=<a href='/topic/show?id=230250248f9' target=_blank style='color:#2F92EE;'>#彩色多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50248, encryptionId=230250248f9, topicName=彩色多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=804e24388072, createdName=wleon8903, createdTime=Tue Dec 04 23:12:00 CST 2018, time=2018-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661544, encodeId=ff48166154426, content=<a href='/topic/show?id=aea3131932d' target=_blank style='color:#2F92EE;'>#OAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13193, encryptionId=aea3131932d, topicName=OAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37ad25322582, createdName=12498561m40(暂无昵称), createdTime=Sat Nov 09 05:12:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666980, encodeId=7613166698080, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Thu Mar 28 09:12:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849623, encodeId=5f1f1849623f1, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Tue Feb 05 14:12:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273716, encodeId=9d8512e371628, content=<a href='/topic/show?id=10a5698555f' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69855, encryptionId=10a5698555f, topicName=甲状腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Tue Nov 27 14:12:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1798701, encodeId=80711e9870135, content=<a href='/topic/show?id=92346985ed2' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69857, encryptionId=92346985ed2, topicName=甲状腺功能亢进视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Mon Feb 25 13:12:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926539, encodeId=0811192653949, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Wed Mar 27 09:12:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812146, encodeId=8b1c181214630, content=<a href='/topic/show?id=536e89169b0' target=_blank style='color:#2F92EE;'>#血流变化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89169, encryptionId=536e89169b0, topicName=血流变化)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Sep 18 12:12:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1768950, encodeId=f0211e6895058, content=<a href='/topic/show?id=9f12432880c' target=_blank style='color:#2F92EE;'>#多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43288, encryptionId=9f12432880c, topicName=多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c58d37960304, createdName=12499e01m59暂无昵称, createdTime=Thu Jun 27 18:12:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857723, encodeId=02ff185e723b9, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jan 20 18:12:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1653874, encodeId=2f3916538e4f8, content=<a href='/topic/show?id=230250248f9' target=_blank style='color:#2F92EE;'>#彩色多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50248, encryptionId=230250248f9, topicName=彩色多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=804e24388072, createdName=wleon8903, createdTime=Tue Dec 04 23:12:00 CST 2018, time=2018-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661544, encodeId=ff48166154426, content=<a href='/topic/show?id=aea3131932d' target=_blank style='color:#2F92EE;'>#OAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13193, encryptionId=aea3131932d, topicName=OAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37ad25322582, createdName=12498561m40(暂无昵称), createdTime=Sat Nov 09 05:12:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666980, encodeId=7613166698080, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Thu Mar 28 09:12:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849623, encodeId=5f1f1849623f1, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Tue Feb 05 14:12:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273716, encodeId=9d8512e371628, content=<a href='/topic/show?id=10a5698555f' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69855, encryptionId=10a5698555f, topicName=甲状腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Tue Nov 27 14:12:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1798701, encodeId=80711e9870135, content=<a href='/topic/show?id=92346985ed2' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69857, encryptionId=92346985ed2, topicName=甲状腺功能亢进视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Mon Feb 25 13:12:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926539, encodeId=0811192653949, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Wed Mar 27 09:12:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812146, encodeId=8b1c181214630, content=<a href='/topic/show?id=536e89169b0' target=_blank style='color:#2F92EE;'>#血流变化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89169, encryptionId=536e89169b0, topicName=血流变化)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Sep 18 12:12:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1768950, encodeId=f0211e6895058, content=<a href='/topic/show?id=9f12432880c' target=_blank style='color:#2F92EE;'>#多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43288, encryptionId=9f12432880c, topicName=多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c58d37960304, createdName=12499e01m59暂无昵称, createdTime=Thu Jun 27 18:12:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857723, encodeId=02ff185e723b9, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jan 20 18:12:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1653874, encodeId=2f3916538e4f8, content=<a href='/topic/show?id=230250248f9' target=_blank style='color:#2F92EE;'>#彩色多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50248, encryptionId=230250248f9, topicName=彩色多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=804e24388072, createdName=wleon8903, createdTime=Tue Dec 04 23:12:00 CST 2018, time=2018-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661544, encodeId=ff48166154426, content=<a href='/topic/show?id=aea3131932d' target=_blank style='color:#2F92EE;'>#OAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13193, encryptionId=aea3131932d, topicName=OAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37ad25322582, createdName=12498561m40(暂无昵称), createdTime=Sat Nov 09 05:12:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666980, encodeId=7613166698080, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Thu Mar 28 09:12:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849623, encodeId=5f1f1849623f1, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Tue Feb 05 14:12:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273716, encodeId=9d8512e371628, content=<a href='/topic/show?id=10a5698555f' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69855, encryptionId=10a5698555f, topicName=甲状腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Tue Nov 27 14:12:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1798701, encodeId=80711e9870135, content=<a href='/topic/show?id=92346985ed2' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69857, encryptionId=92346985ed2, topicName=甲状腺功能亢进视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Mon Feb 25 13:12:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926539, encodeId=0811192653949, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Wed Mar 27 09:12:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812146, encodeId=8b1c181214630, content=<a href='/topic/show?id=536e89169b0' target=_blank style='color:#2F92EE;'>#血流变化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89169, encryptionId=536e89169b0, topicName=血流变化)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Sep 18 12:12:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1768950, encodeId=f0211e6895058, content=<a href='/topic/show?id=9f12432880c' target=_blank style='color:#2F92EE;'>#多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43288, encryptionId=9f12432880c, topicName=多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c58d37960304, createdName=12499e01m59暂无昵称, createdTime=Thu Jun 27 18:12:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857723, encodeId=02ff185e723b9, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jan 20 18:12:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1653874, encodeId=2f3916538e4f8, content=<a href='/topic/show?id=230250248f9' target=_blank style='color:#2F92EE;'>#彩色多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50248, encryptionId=230250248f9, topicName=彩色多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=804e24388072, createdName=wleon8903, createdTime=Tue Dec 04 23:12:00 CST 2018, time=2018-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661544, encodeId=ff48166154426, content=<a href='/topic/show?id=aea3131932d' target=_blank style='color:#2F92EE;'>#OAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13193, encryptionId=aea3131932d, topicName=OAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37ad25322582, createdName=12498561m40(暂无昵称), createdTime=Sat Nov 09 05:12:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666980, encodeId=7613166698080, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Thu Mar 28 09:12:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849623, encodeId=5f1f1849623f1, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Tue Feb 05 14:12:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273716, encodeId=9d8512e371628, content=<a href='/topic/show?id=10a5698555f' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69855, encryptionId=10a5698555f, topicName=甲状腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Tue Nov 27 14:12:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1798701, encodeId=80711e9870135, content=<a href='/topic/show?id=92346985ed2' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69857, encryptionId=92346985ed2, topicName=甲状腺功能亢进视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Mon Feb 25 13:12:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926539, encodeId=0811192653949, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Wed Mar 27 09:12:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812146, encodeId=8b1c181214630, content=<a href='/topic/show?id=536e89169b0' target=_blank style='color:#2F92EE;'>#血流变化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89169, encryptionId=536e89169b0, topicName=血流变化)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Sep 18 12:12:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1768950, encodeId=f0211e6895058, content=<a href='/topic/show?id=9f12432880c' target=_blank style='color:#2F92EE;'>#多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43288, encryptionId=9f12432880c, topicName=多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c58d37960304, createdName=12499e01m59暂无昵称, createdTime=Thu Jun 27 18:12:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857723, encodeId=02ff185e723b9, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jan 20 18:12:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1653874, encodeId=2f3916538e4f8, content=<a href='/topic/show?id=230250248f9' target=_blank style='color:#2F92EE;'>#彩色多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50248, encryptionId=230250248f9, topicName=彩色多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=804e24388072, createdName=wleon8903, createdTime=Tue Dec 04 23:12:00 CST 2018, time=2018-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661544, encodeId=ff48166154426, content=<a href='/topic/show?id=aea3131932d' target=_blank style='color:#2F92EE;'>#OAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13193, encryptionId=aea3131932d, topicName=OAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37ad25322582, createdName=12498561m40(暂无昵称), createdTime=Sat Nov 09 05:12:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666980, encodeId=7613166698080, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Thu Mar 28 09:12:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849623, encodeId=5f1f1849623f1, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Tue Feb 05 14:12:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273716, encodeId=9d8512e371628, content=<a href='/topic/show?id=10a5698555f' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69855, encryptionId=10a5698555f, topicName=甲状腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Tue Nov 27 14:12:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]
    2019-03-28 gj0740
  9. [GetPortalCommentsPageByObjectIdResponse(id=1798701, encodeId=80711e9870135, content=<a href='/topic/show?id=92346985ed2' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69857, encryptionId=92346985ed2, topicName=甲状腺功能亢进视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Mon Feb 25 13:12:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926539, encodeId=0811192653949, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Wed Mar 27 09:12:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812146, encodeId=8b1c181214630, content=<a href='/topic/show?id=536e89169b0' target=_blank style='color:#2F92EE;'>#血流变化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89169, encryptionId=536e89169b0, topicName=血流变化)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Sep 18 12:12:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1768950, encodeId=f0211e6895058, content=<a href='/topic/show?id=9f12432880c' target=_blank style='color:#2F92EE;'>#多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43288, encryptionId=9f12432880c, topicName=多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c58d37960304, createdName=12499e01m59暂无昵称, createdTime=Thu Jun 27 18:12:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857723, encodeId=02ff185e723b9, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jan 20 18:12:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1653874, encodeId=2f3916538e4f8, content=<a href='/topic/show?id=230250248f9' target=_blank style='color:#2F92EE;'>#彩色多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50248, encryptionId=230250248f9, topicName=彩色多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=804e24388072, createdName=wleon8903, createdTime=Tue Dec 04 23:12:00 CST 2018, time=2018-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661544, encodeId=ff48166154426, content=<a href='/topic/show?id=aea3131932d' target=_blank style='color:#2F92EE;'>#OAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13193, encryptionId=aea3131932d, topicName=OAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37ad25322582, createdName=12498561m40(暂无昵称), createdTime=Sat Nov 09 05:12:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666980, encodeId=7613166698080, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Thu Mar 28 09:12:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849623, encodeId=5f1f1849623f1, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Tue Feb 05 14:12:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273716, encodeId=9d8512e371628, content=<a href='/topic/show?id=10a5698555f' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69855, encryptionId=10a5698555f, topicName=甲状腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Tue Nov 27 14:12:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]
    2019-02-05 windight
  10. [GetPortalCommentsPageByObjectIdResponse(id=1798701, encodeId=80711e9870135, content=<a href='/topic/show?id=92346985ed2' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69857, encryptionId=92346985ed2, topicName=甲状腺功能亢进视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Mon Feb 25 13:12:00 CST 2019, time=2019-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926539, encodeId=0811192653949, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Wed Mar 27 09:12:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1812146, encodeId=8b1c181214630, content=<a href='/topic/show?id=536e89169b0' target=_blank style='color:#2F92EE;'>#血流变化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89169, encryptionId=536e89169b0, topicName=血流变化)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Wed Sep 18 12:12:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1768950, encodeId=f0211e6895058, content=<a href='/topic/show?id=9f12432880c' target=_blank style='color:#2F92EE;'>#多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43288, encryptionId=9f12432880c, topicName=多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c58d37960304, createdName=12499e01m59暂无昵称, createdTime=Thu Jun 27 18:12:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857723, encodeId=02ff185e723b9, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Sun Jan 20 18:12:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1653874, encodeId=2f3916538e4f8, content=<a href='/topic/show?id=230250248f9' target=_blank style='color:#2F92EE;'>#彩色多普勒超声#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50248, encryptionId=230250248f9, topicName=彩色多普勒超声)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=804e24388072, createdName=wleon8903, createdTime=Tue Dec 04 23:12:00 CST 2018, time=2018-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661544, encodeId=ff48166154426, content=<a href='/topic/show?id=aea3131932d' target=_blank style='color:#2F92EE;'>#OAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13193, encryptionId=aea3131932d, topicName=OAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37ad25322582, createdName=12498561m40(暂无昵称), createdTime=Sat Nov 09 05:12:00 CST 2019, time=2019-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666980, encodeId=7613166698080, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Thu Mar 28 09:12:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849623, encodeId=5f1f1849623f1, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Tue Feb 05 14:12:00 CST 2019, time=2019-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273716, encodeId=9d8512e371628, content=<a href='/topic/show?id=10a5698555f' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69855, encryptionId=10a5698555f, topicName=甲状腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Tue Nov 27 14:12:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]

相关资讯

Spine:彩色多普勒超声在腰痛患者腰椎动脉血流探测中的应用

充足的血流供因对腰椎正常功能的维持非常重要:骨间的毛细血管血供来源于腰动脉;椎间盘的学运来源于骨间的毛细血管网;上述血管血运的破坏可以导致椎间盘及其它重要结构的血供障碍,从而产生相应疾病状态。有学者认为,腹部大动脉的粥样斑块等病变可以导致腰动脉血运减少,从而诱发椎间盘退变及腰痛,因此对腰部血管血流动力学的研究有助于临床医生更好的理解它们和椎间盘退变,腰痛等相关性。 目前关于正常人群和腰痛人群的腰

Int Ophthalmol.:减肥手术对肥胖患者眼球后血液动力学参数的影响:多普勒彩超研究!

土耳其安塔利亚研究医院放射科的?eki? B近日在Int Ophthalmol.杂志上发表了一项重要的工作。他们在进行减肥手术的患者中,用彩色多普勒超声(CDU)的方法研究了体重减轻对眼球后血流动力学的影响,并使用高德曼眼压测量法测量眼内压(IOP)的变化。

JCEM:彩色多普勒超声对甲状腺结节患儿的诊断准确性!

由此可见,超声检查对甲状腺结节的评估很有用,但是发现没有超声特征的组合足以在没有活检的情况下排除甲状腺癌。

Baidu
map
Baidu
map
Baidu
map